Cardiovascular biomarkers in pregnancy with diabetes and associations to glucose control.
Daniel Pitz JacobsenRagnhild RøyslandHeidi StrandKjartan MoeMeryam SugulleTorbjørn OmlandAnne Cathrine StaffPublished in: Acta diabetologica (2022)
Our results support the presence of myocardial affection in women with diabetic disorders during pregnancy. Although pregestational DM1 in this study was associated with the most adverse CVD biomarker profile, women with GDM displayed an adverse cTnT profile similar to what we found in women with pregestational DM2. This supports that women with GDM should be offered long-term intensified cardiovascular follow-up and lifestyle advice following delivery, similarly to the well-established CV follow-up of women with pregestational DM.